SCHEMBL9491302

SCHEMBL9491302

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.53
▸ ENPEP Q07075 7/20 0.50
▸ SLC7A5 Q01650 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CA2 P00918 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CTSD P07339 1/20 0.41
▸ FPR2 P25090 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ SLC1A3 P43003 1/20 0.41
▸ SLC1A2 P43004 1/20 0.41
▸ LARS1 Q9P2J5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14941289 1.00 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5L3MBTL1CA2
SCHEMBL9491298 1.00 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5L3MBTL1CA2
SCHEMBL16698375 1.00 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5L3MBTL1CA2
SCHEMBL29351914 0.97 ALDH1A1 (0.50) ALDH1A1ENPEPSLC7A5L3MBTL1CTSD
SCHEMBL30051564 0.94 ALDH1A1 (0.47) ALDH1A1ENPEPSLC7A5L3MBTL1CTSD
SCHEMBL30052478 0.94 ALDH1A1 (0.47) ALDH1A1ENPEPSLC7A5L3MBTL1CA2
SCHEMBL16698982 0.93 ALDH1A1 (0.46) ALDH1A1ENPEPSLC7A5L3MBTL1CTSD
SCHEMBL29350950 0.93 ALDH1A1 (0.46) ALDH1A1ENPEPSLC7A5L3MBTL1CA2
SCHEMBL16698981 0.93 ALDH1A1 (0.46) ALDH1A1ENPEPSLC7A5L3MBTL1CTSD
SCHEMBL29453382 0.91 CTSD (0.48) ALDH1A1ENPEPSLC7A5CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250296971-A1 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-09-25 — — US claimed
CN-118632858-A Gastric inhibitory peptide receptor ligands 3B制药有限公司 2024-09-10 — — CN claimed
EP-4423110-A2 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS 3B Pharmaceuticals GmbH (DE) 2024-09-04 — — EP claimed
CN-118291569-A Yellow chicken oligopeptide and preparation method and application thereof 中国食品发酵工业研究院有限公司 2024-07-05 — — CN claimed
CN-117990922-A Metabolic marker for diabetes combined coronary heart disease diagnosis and application 哈尔滨脉图精准技术有限公司 2024-05-07 — — CN claimed
EP-4277652-A1 HIV VACCINES AND METHODS OF USING GILEAD SCIENCES, INC. (US) 2023-11-22 — — EP claimed
CN-116847882-A HIV vaccine and methods of use thereof 吉利德科学公司 2023-10-03 — — CN claimed
CN-116425838-A Polypeptide compound and medical application thereof 北京拓界生物医药科技有限公司 2023-07-14 — — CN claimed
CN-116298013-A Identification method based on saliva metabonomics 山东第一医科大学附属省立医院(山东省立医院) 2023-06-23 — — CN claimed
WO-2023072971-A2 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2023-05-04 — — WO claimed
WO-2022155258-A1 HIV VACCINES AND METHODS OF USING GILEAD SCIENCES, INC. (US) 2022-07-21 — — WO claimed
WO-2022148418-A1 PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER 江苏恒瑞医药股份有限公司 2022-07-14 — — WO claimed
US-20150132440-A1 DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES JHO INTELLECTUAL PROPERTY HOLDINGS, LLC 2015-05-14 — — US claimed
CN-103163269-B Method for fast identifying fermented soy sauce and blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2014-12-17 — — CN claimed
CN-103163248-B Method for identifying blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2014-05-28 — — CN claimed
CN-103163248-A Method for identifying blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2013-06-19 — — CN claimed
CN-103163269-A Method for fast identifying fermented soy sauce and blended soy sauce FOSHAN HAITIAN FLAVORING & FOOD CO LTD 2013-06-19 — — CN claimed
WO-2026107097-A1 SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF ENLAZA THERAPEUTICS, INC. (US) 2026-05-21 — — WO disclosed
US-5036052-A Containing a dipeptide of tryptophan and alanine or lecine and no stabilizer; discoloration inhibition MORISHITA PHARMACEUTICAL CO., LTD. (JP) 1991-07-30 — — US disclosed
EP-0347890-A1 Amino acid nutrient compositions Roussel Morishita Co., Ltd. (JP) 1989-12-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250296971-A1 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS GIPR, VIP, GRPR ALDH1A1 3223/4885ENPEP 400/4885SLC7A5 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback